Even though the identification of conolidine as a potential novel analgesic agent delivers yet another avenue to address the opioid disaster and handle CNCP, even more reports are required to be familiar with its system of motion and utility and efficacy in taking care of CNCP.A: Though conolidine exhibits guarantee for lengthy-expression suffering